Active Ingredient(s): Gemifloxacin
FDA Approved: * April 4, 2003
Pharm Company: * OSCIENT
Category: Antibiotics

Gemifloxacin mesylate (trade name Factive, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. Vansen Pharma Inc. has licensed the active ingredient from LG Life Sciences of Korea. Contents 1 Indications 2 Microbiology 3 Adverse effects 4 Current findings 5 See also 6 References Indications Gemifloxacin is indicated for the treatment of infections ca... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Factive 320 mg Oral Tablet
NDC: 10122-321
Cornerstone Therapeutics Inc.
Factive 320 mg Oral Tablet
NDC: 44001-321
Merus Labs International Inc.
Factive (Gemifloxacin 320 mg)
NDC: 44004-321
Vansen Pharma Inc.
Factive 320 mg Oral Tablet
NDC: 67707-320
Oscient Pharmaceuticals

Popular Topics


pharengeal problems...